Company Filing History:
1 out of 1 
1 out of 26 Years Active: 2005
Title: Innovations of Désire José Collen
Introduction
Désire José Collen is a notable inventor based in Winksele-Herent, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of staphylokinase derivatives. His work focuses on enhancing the therapeutic applications of these derivatives while minimizing their immunogenicity in patients.
Latest Patents
Collen holds a patent for "Staphylokinase derivatives with polyethyleneglycol - Methods for the identification, production and use of staphylokinase derivatives characterized by a reduced immunogenicity after administration in patients." This innovative patent outlines a method for producing staphylokinase derivatives through a series of precise genetic manipulations. The process involves preparing a DNA fragment that encodes the staphylokinase protein, performing site-directed mutagenesis, and expressing the modified protein in suitable host cells. The resulting derivatives are intended for use in pharmaceutical compositions aimed at treating arterial thrombosis.
Career Highlights
Throughout his career, Désire José Collen has been associated with various research initiatives and organizations. He has worked with companies such as Desire' Jose' Collen and Leuven Research & Development Vzw. His expertise in biotechnology and patent development has positioned him as a key figure in his field.
Collaborations
Due to space constraints, the details of his collaborations will not be included.
Conclusion
Désire José Collen's innovative work in the field of staphylokinase derivatives showcases his commitment to advancing medical treatments. His contributions have the potential to significantly impact the management of arterial thrombosis and improve patient outcomes.